Physician profile
Earl Brien
NPI 1518024702
$47,554.58
in general payments reported to CMS, 2019-2025
10 companies · $5,240 in 2025
The $5,240 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,766 · 2020: $305 · 2021: $7,293 · 2022: $15K · 2023: $18K · 2024: $272 · 2025: $5,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $911 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,942.50 |
| Food and Beverage | $911.15 |
| Travel and Lodging | $337.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uoc USA INC | $44,477.13 | 2020-2025 | Ustar II, U-Star II, U-Motion II |
| Daiichi Sankyo INC. | $1,845.99 | 2019-2021 | |
| Stryker Corporation | $338.70 | 2022-2024 | Mako |
| Carbofix Orthopedics INC | $253.40 | 2022-2024 | |
| Convatec INC. | $204.11 | 2021-2023 | |
| Illuminoss Medical, INC. | $169.04 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Acumed LLC | $110.44 | 2020 | |
| Biocomposites INC | $95.00 | 2021 | |
| Leica Microsystems INC. | $40.00 | 2019 | |
| Checkpoint Surgical, INC | $20.77 | 2023 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Brien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.